APO Research

APO RESEARCH · REPORT

Keratin 18 Antibody

Selected research

Industry Growth & Trends

Global Keratin 18 Antibody Industry Growth and Trends Forecast to 2032

Market perspective

The global Keratin 18 Antibody market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Keratin 18 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Keratin 18 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Keratin 18 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Keratin 18 Antibody include HUABIO, Abcam, Abnova, Bioss, Creative Biolabs, Creative Diagnostics, CUSABIO, GeneTex and OriGene Technologies, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Keratin 18 Antibody market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Keratin 18 Antibody market size, estimates, and forecasts are presented in terms of sales volume (ml) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Keratin 18 Antibody market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Keratin 18 Antibody.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Keratin 18 Antibody market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Keratin 18 Antibody Market by Company

HUABIO

Abcam

Abnova

Bioss

Creative Biolabs

Creative Diagnostics

CUSABIO

GeneTex

OriGene Technologies

ProSci

Boster Biological Technology

United States Biological

Keratin 18 Antibody Segment by Type

Polyclonal

Monoclonal

Keratin 18 Antibody Segment by Application

Immunohistochemistry

Enzyme Linked Immunosorbent Assay

Western Blot

Others

Keratin 18 Antibody Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Keratin 18 Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Keratin 18 Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Keratin 18 Antibody.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Keratin 18 Antibody manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Keratin 18 Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Polyclonal Table 2. Major Company of Monoclonal Table 3. Global Keratin 18 Antibody Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Keratin 18 Antibody Sales by Type (2021-2026) & (ml) Table 5. Global Keratin 18 Antibody Sales Market Share in Volume by Type (2021-2026) Table 6. Global Keratin 18 Antibody Sales by Type (2021-2026) & (US$ Million) Table 7. Global Keratin 18 Antibody Sales Market Share in Value by Type (2021-2026) Table 8. Global Keratin 18 Antibody Price by Type (2021-2026) & (US$/ml) Table 9. Global Keratin 18 Antibody Sales by Type (2027-2032) & (ml) Table 10. Global Keratin 18 Antibody Sales Market Share in Volume by Type (2027-2032) Table 11. Global Keratin 18 Antibody Sales by Type (2027-2032) & (US$ Million) Table 12. Global Keratin 18 Antibody Sales Market Share in Value by Type (2027-2032) Table 13. Global Keratin 18 Antibody Price by Type (2027-2032) & (US$/ml) Table 14. North America Keratin 18 Antibody Sales by Type (2021-2026) & (ml) Table 15. North America Keratin 18 Antibody Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Keratin 18 Antibody Sales by Type (2021-2026) & (ml) Table 17. Europe Keratin 18 Antibody Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Keratin 18 Antibody Sales by Type (2021-2026) & (ml) Table 19. Asia-Pacific Keratin 18 Antibody Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Keratin 18 Antibody Sales by Type (2021-2026) & (ml) Table 21. Latin America Keratin 18 Antibody Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Keratin 18 Antibody Sales by Type (2021-2026) & (ml) Table 23. Middle East and Africa Keratin 18 Antibody Sales by Type (2021-2026) & (US$ Million) Table 24. Keratin 18 Antibody Industry Trends Table 25. Keratin 18 Antibody Industry Drivers Table 26. Keratin 18 Antibody Industry Opportunities and Challenges Table 27. Keratin 18 Antibody Industry Restraints Table 28. Global Keratin 18 Antibody Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Keratin 18 Antibody Revenue Market Share by Company (2021-2026) Table 30. Global Keratin 18 Antibody Sales by Company (2021-2026) & (ml) Table 31. Global Keratin 18 Antibody Sales Share by Company (2021-2026) Table 32. Global Keratin 18 Antibody Market Price by Company (2021-2026) & (US$/ml) Table 33. Global Keratin 18 Antibody Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Keratin 18 Antibody Major Company Production Sites and Headquarters Table 35. Global Keratin 18 Antibody Company, Product Type & Application Table 36. Global Keratin 18 Antibody Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Keratin 18 Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Keratin 18 Antibody Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Keratin 18 Antibody Sales by Region (2021-2026) & (ml) Table 41. Global Keratin 18 Antibody Sales Market Share in Volume by Region (2021-2026) Table 42. Global Keratin 18 Antibody Sales by Region (2021-2026) & (US$ Million) Table 43. Global Keratin 18 Antibody Sales Market Share in Value by Region (2021-2026) Table 44. Global Keratin 18 Antibody Sales (ml), Value (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 45. Global Keratin 18 Antibody Sales by Region (2027-2032) & (ml) Table 46. Global Keratin 18 Antibody Sales Market Share in Volume by Region (2027-2032) Table 47. Global Keratin 18 Antibody Sales by Region (2027-2032) & (US$ Million) Table 48. Global Keratin 18 Antibody Sales Market Share in Value by Region (2027-2032) Table 49. Global Keratin 18 Antibody Sales (ml), Value (US$ Million), Price (US$/ml) and Gross Margin (2027-2032) Table 50. Global Keratin 18 Antibody Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Keratin 18 Antibody Sales by Application (2021-2026) & (ml) Table 52. Global Keratin 18 Antibody Sales Market Share in Volume by Application (2021-2026) Table 53. Global Keratin 18 Antibody Sales by Application (2021-2026) & (US$ Million) Table 54. Global Keratin 18 Antibody Sales Market Share in Value by Application (2021-2026) Table 55. Global Keratin 18 Antibody Price by Application (2021-2026) & (US$/ml) Table 56. Global Keratin 18 Antibody Sales by Application (2027-2032) & (ml) Table 57. Global Keratin 18 Antibody Sales Market Share in Volume by Application (2027-2032) Table 58. Global Keratin 18 Antibody Sales by Application (2027-2032) & (US$ Million) Table 59. Global Keratin 18 Antibody Sales Market Share in Value by Application (2027-2032) Table 60. Global Keratin 18 Antibody Price by Application (2027-2032) & (US$/ml) Table 61. North America Keratin 18 Antibody Sales by Application (2021-2026) & (ml) Table 62. North America Keratin 18 Antibody Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Keratin 18 Antibody Sales by Application (2021-2026) & (ml) Table 64. Europe Keratin 18 Antibody Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Keratin 18 Antibody Sales by Application (2021-2026) & (ml) Table 66. Asia-Pacific Keratin 18 Antibody Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Keratin 18 Antibody Sales by Application (2021-2026) & (ml) Table 68. Latin America Keratin 18 Antibody Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Keratin 18 Antibody Sales by Application (2021-2026) & (ml) Table 70. Middle East and Africa Keratin 18 Antibody Sales by Application (2021-2026) & (US$ Million) Table 71. HUABIO Company Information Table 72. HUABIO Business Overview Table 73. HUABIO Keratin 18 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 74. HUABIO Keratin 18 Antibody Product Portfolio Table 75. HUABIO Recent Development Table 76. Abcam Company Information Table 77. Abcam Business Overview Table 78. Abcam Keratin 18 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 79. Abcam Keratin 18 Antibody Product Portfolio Table 80. Abcam Recent Development Table 81. Abnova Company Information Table 82. Abnova Business Overview Table 83. Abnova Keratin 18 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 84. Abnova Keratin 18 Antibody Product Portfolio Table 85. Abnova Recent Development Table 86. Bioss Company Information Table 87. Bioss Business Overview Table 88. Bioss Keratin 18 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 89. Bioss Keratin 18 Antibody Product Portfolio Table 90. Bioss Recent Development Table 91. Creative Biolabs Company Information Table 92. Creative Biolabs Business Overview Table 93. Creative Biolabs Keratin 18 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 94. Creative Biolabs Keratin 18 Antibody Product Portfolio Table 95. Creative Biolabs Recent Development Table 96. Creative Diagnostics Company Information Table 97. Creative Diagnostics Business Overview Table 98. Creative Diagnostics Keratin 18 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 99. Creative Diagnostics Keratin 18 Antibody Product Portfolio Table 100. Creative Diagnostics Recent Development Table 101. CUSABIO Company Information Table 102. CUSABIO Business Overview Table 103. CUSABIO Keratin 18 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 104. CUSABIO Keratin 18 Antibody Product Portfolio Table 105. CUSABIO Recent Development Table 106. GeneTex Company Information Table 107. GeneTex Business Overview Table 108. GeneTex Keratin 18 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 109. GeneTex Keratin 18 Antibody Product Portfolio Table 110. GeneTex Recent Development Table 111. OriGene Technologies Company Information Table 112. OriGene Technologies Business Overview Table 113. OriGene Technologies Keratin 18 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 114. OriGene Technologies Keratin 18 Antibody Product Portfolio Table 115. OriGene Technologies Recent Development Table 116. ProSci Company Information Table 117. ProSci Business Overview Table 118. ProSci Keratin 18 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 119. ProSci Keratin 18 Antibody Product Portfolio Table 120. ProSci Recent Development Table 121. Boster Biological Technology Company Information Table 122. Boster Biological Technology Business Overview Table 123. Boster Biological Technology Keratin 18 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 124. Boster Biological Technology Keratin 18 Antibody Product Portfolio Table 125. Boster Biological Technology Recent Development Table 126. United States Biological Company Information Table 127. United States Biological Business Overview Table 128. United States Biological Keratin 18 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 129. United States Biological Keratin 18 Antibody Product Portfolio Table 130. United States Biological Recent Development Table 131. North America Keratin 18 Antibody Market Size Growth Rate (CAGR) by Country (ml): 2021 VS 2025 VS 2032 Table 132. North America Keratin 18 Antibody Sales by Country (2021-2026) & (ml) Table 133. North America Keratin 18 Antibody Sales Market Share by Country (2021-2026) Table 134. North America Keratin 18 Antibody Sales Forecast by Country (2027-2032) & (ml) Table 135. North America Keratin 18 Antibody Sales Market Share Forecast by Country (2027-2032) Table 136. North America Keratin 18 Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. North America Keratin 18 Antibody Market Size by Country (2021-2026) & (US$ Million) Table 138. North America Keratin 18 Antibody Market Share by Country (2021-2026) Table 139. North America Keratin 18 Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. North America Keratin 18 Antibody Market Share Forecast by Country (2027-2032) Table 141. Europe Keratin 18 Antibody Market Size Growth Rate (CAGR) by Country (ml): 2021 VS 2025 VS 2032 Table 142. Europe Keratin 18 Antibody Sales by Country (2021-2026) & (ml) Table 143. Europe Keratin 18 Antibody Sales Market Share by Country (2021-2026) Table 144. Europe Keratin 18 Antibody Sales Forecast by Country (2027-2032) & (ml) Table 145. Europe Keratin 18 Antibody Sales Market Share Forecast by Country (2027-2032) Table 146. Europe Keratin 18 Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Europe Keratin 18 Antibody Market Size by Country (2021-2026) & (US$ Million) Table 148. Europe Keratin 18 Antibody Market Share by Country (2021-2026) Table 149. Europe Keratin 18 Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Europe Keratin 18 Antibody Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Keratin 18 Antibody Market Size Growth Rate (CAGR) by Country (ml): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Keratin 18 Antibody Sales by Country (2021-2026) & (ml) Table 153. Asia-Pacific Keratin 18 Antibody Sales Market Share by Country (2021-2026) Table 154. Asia-Pacific Keratin 18 Antibody Sales Forecast by Country (2027-2032) & (ml) Table 155. Asia-Pacific Keratin 18 Antibody Sales Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Keratin 18 Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Keratin 18 Antibody Market Size by Country (2021-2026) & (US$ Million) Table 158. Asia-Pacific Keratin 18 Antibody Market Share by Country (2021-2026) Table 159. Asia-Pacific Keratin 18 Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Asia-Pacific Keratin 18 Antibody Market Share Forecast by Country (2027-2032) Table 161. Latin America Keratin 18 Antibody Market Size Growth Rate (CAGR) by Country (ml): 2021 VS 2025 VS 2032 Table 162. Latin America Keratin 18 Antibody Sales by Country (2021-2026) & (ml) Table 163. Latin America Keratin 18 Antibody Sales Market Share by Country (2021-2026) Table 164. Latin America Keratin 18 Antibody Sales Forecast by Country (2027-2032) & (ml) Table 165. Latin America Keratin 18 Antibody Sales Market Share Forecast by Country (2027-2032) Table 166. Latin America Keratin 18 Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Latin America Keratin 18 Antibody Market Size by Country (2021-2026) & (US$ Million) Table 168. Latin America Keratin 18 Antibody Market Share by Country (2021-2026) Table 169. Latin America Keratin 18 Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Latin America Keratin 18 Antibody Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Keratin 18 Antibody Market Size Growth Rate (CAGR) by Country (ml): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Keratin 18 Antibody Sales by Country (2021-2026) & (ml) Table 173. Middle East and Africa Keratin 18 Antibody Sales Market Share by Country (2021-2026) Table 174. Middle East and Africa Keratin 18 Antibody Sales Forecast by Country (2027-2032) & (ml) Table 175. Middle East and Africa Keratin 18 Antibody Sales Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Keratin 18 Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Keratin 18 Antibody Market Size by Country (2021-2026) & (US$ Million) Table 178. Middle East and Africa Keratin 18 Antibody Market Share by Country (2021-2026) Table 179. Middle East and Africa Keratin 18 Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Middle East and Africa Keratin 18 Antibody Market Share Forecast by Country (2027-2032) Table 181. Key Raw Materials Table 182. Raw Materials Key Suppliers Table 183. Keratin 18 Antibody Distributors List Table 184. Keratin 18 Antibody Customers List Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. Keratin 18 Antibody Image Figure 2. Global Keratin 18 Antibody Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Keratin 18 Antibody Market Size (2021-2032) & (US$ Million) Figure 4. Global Keratin 18 Antibody Sales (2021-2032) & (ml) Figure 5. Polyclonal Image Figure 6. Global Polyclonal Sales YoY Growth (2021-2032) & (ml) Figure 7. Monoclonal Image Figure 8. Global Monoclonal Sales YoY Growth (2021-2032) & (ml) Figure 9. Global Keratin 18 Antibody Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Keratin 18 Antibody Market Share by Type 2025 VS 2032 Figure 11. North America Keratin 18 Antibody Sales Market Share in Volume by Type in 2025 Figure 12. North America Keratin 18 Antibody Sales Market Share in Value by Type in 2025 Figure 13. Europe Keratin 18 Antibody Sales Market Share in Volume by Type in 2025 Figure 14. Europe Keratin 18 Antibody Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Keratin 18 Antibody Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Keratin 18 Antibody Sales Market Share in Value by Type in 2025 Figure 17. Latin America Keratin 18 Antibody Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Keratin 18 Antibody Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Keratin 18 Antibody Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Keratin 18 Antibody Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Keratin 18 Antibody Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Immunohistochemistry Image Figure 24. Global Immunohistochemistry Sales YoY Growth (2021-2032) & (ml) Figure 25. Enzyme Linked Immunosorbent Assay Image Figure 26. Global Enzyme Linked Immunosorbent Assay Sales YoY Growth (2021-2032) & (ml) Figure 27. Western Blot Image Figure 28. Global Western Blot Sales YoY Growth (2021-2032) & (ml) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (ml) Figure 31. Global Keratin 18 Antibody Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Keratin 18 Antibody Market Share by Application 2025 VS 2032 Figure 33. North America Keratin 18 Antibody Sales Market Share in Volume by Application in 2025 Figure 34. North America Keratin 18 Antibody Sales Market Share in Value by Application in 2025 Figure 35. Europe Keratin 18 Antibody Sales Market Share in Volume by Application in 2025 Figure 36. Europe Keratin 18 Antibody Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Keratin 18 Antibody Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Keratin 18 Antibody Sales Market Share in Value by Application in 2025 Figure 39. Latin America Keratin 18 Antibody Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Keratin 18 Antibody Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Keratin 18 Antibody Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Keratin 18 Antibody Sales Market Share in Value by Application in 2025 Figure 43. North America Keratin 18 Antibody Sales by Country: 2021 VS 2025 VS 2032 (ml) Figure 44. North America Keratin 18 Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Keratin 18 Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Keratin 18 Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Keratin 18 Antibody Sales by Country: 2021 VS 2025 VS 2032 (ml) Figure 48. Europe Keratin 18 Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Keratin 18 Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Keratin 18 Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Keratin 18 Antibody Sales by Country: 2021 VS 2025 VS 2032 (ml) Figure 52. Asia-Pacific Keratin 18 Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Keratin 18 Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Keratin 18 Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Keratin 18 Antibody Sales by Country: 2021 VS 2025 VS 2032 (ml) Figure 56. Latin America Keratin 18 Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Keratin 18 Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Keratin 18 Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Keratin 18 Antibody Sales by Country: 2021 VS 2025 VS 2032 (ml) Figure 60. Middle East and Africa Keratin 18 Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Keratin 18 Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Keratin 18 Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Keratin 18 Antibody Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Keratin 18 Antibody Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Polyclonal
  • Monoclonal
Applications
  • Immunohistochemistry
  • Enzyme Linked Immunosorbent Assay
  • Western Blot
  • Others
Companies covered
  • HUABIO
  • Abcam
  • Abnova
  • Bioss
  • Creative Biolabs
  • Creative Diagnostics
  • CUSABIO
  • GeneTex
  • OriGene Technologies
  • ProSci
  • Boster Biological Technology
  • United States Biological

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Keratin 18 Antibody Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Keratin 18 Antibody Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Keratin 18 Antibody Market by Type
  6. 1.3.1 Polyclonal
  7. 1.3.2 Monoclonal
  8. 1.4 Global Keratin 18 Antibody Market Size by Type
  9. 1.4.1 Global Keratin 18 Antibody Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Keratin 18 Antibody Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Keratin 18 Antibody Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Keratin 18 Antibody Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Keratin 18 Antibody Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Keratin 18 Antibody Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Keratin 18 Antibody Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Keratin 18 Antibody Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Keratin 18 Antibody Industry Trends
  2. 2.2 Keratin 18 Antibody Industry Drivers
  3. 2.3 Keratin 18 Antibody Industry Opportunities and Challenges
  4. 2.4 Keratin 18 Antibody Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Keratin 18 Antibody Revenue (2021-2026)
  2. 3.2 Global Top Players by Keratin 18 Antibody Sales (2021-2026)
  3. 3.3 Global Top Players by Keratin 18 Antibody Price (2021-2026)
  4. 3.4 Global Keratin 18 Antibody Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Keratin 18 Antibody Major Company Production Sites & Headquarters
  6. 3.6 Global Keratin 18 Antibody Company, Product Type & Application
  7. 3.7 Global Keratin 18 Antibody Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Keratin 18 Antibody Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Keratin 18 Antibody Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Keratin 18 Antibody Tier 1, Tier 2, and Tier 3
4 Keratin 18 Antibody Regional Status and Outlook
  1. 4.1 Global Keratin 18 Antibody Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Keratin 18 Antibody Historic Market Size by Region
  3. 4.2.1 Global Keratin 18 Antibody Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Keratin 18 Antibody Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Keratin 18 Antibody Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Keratin 18 Antibody Forecasted Market Size by Region
  7. 4.3.1 Global Keratin 18 Antibody Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Keratin 18 Antibody Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Keratin 18 Antibody Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Keratin 18 Antibody by Application
  1. 5.1 Keratin 18 Antibody Market by Application
  2. 5.1.1 Immunohistochemistry
  3. 5.1.2 Enzyme Linked Immunosorbent Assay
  4. 5.1.3 Western Blot
  5. 5.1.4 Others
  6. 5.2 Global Keratin 18 Antibody Market Size by Application
  7. 5.2.1 Global Keratin 18 Antibody Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Keratin 18 Antibody Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Keratin 18 Antibody Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Keratin 18 Antibody Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Keratin 18 Antibody Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Keratin 18 Antibody Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Keratin 18 Antibody Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Keratin 18 Antibody Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 HUABIO
  2. 6.1.1 HUABIO Company Information
  3. 6.1.2 HUABIO Business Overview
  4. 6.1.3 HUABIO Keratin 18 Antibody Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 HUABIO Keratin 18 Antibody Product Portfolio
  6. 6.1.5 HUABIO Recent Developments
  7. 6.2 Abcam
  8. 6.2.1 Abcam Company Information
  9. 6.2.2 Abcam Business Overview
  10. 6.2.3 Abcam Keratin 18 Antibody Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Abcam Keratin 18 Antibody Product Portfolio
  12. 6.2.5 Abcam Recent Developments
  13. 6.3 Abnova
  14. 6.3.1 Abnova Company Information
  15. 6.3.2 Abnova Business Overview
  16. 6.3.3 Abnova Keratin 18 Antibody Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Abnova Keratin 18 Antibody Product Portfolio
  18. 6.3.5 Abnova Recent Developments
  19. 6.4 Bioss
  20. 6.4.1 Bioss Company Information
  21. 6.4.2 Bioss Business Overview
  22. 6.4.3 Bioss Keratin 18 Antibody Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bioss Keratin 18 Antibody Product Portfolio
  24. 6.4.5 Bioss Recent Developments
  25. 6.5 Creative Biolabs
  26. 6.5.1 Creative Biolabs Company Information
  27. 6.5.2 Creative Biolabs Business Overview
  28. 6.5.3 Creative Biolabs Keratin 18 Antibody Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Creative Biolabs Keratin 18 Antibody Product Portfolio
  30. 6.5.5 Creative Biolabs Recent Developments
  31. 6.6 Creative Diagnostics
  32. 6.6.1 Creative Diagnostics Company Information
  33. 6.6.2 Creative Diagnostics Business Overview
  34. 6.6.3 Creative Diagnostics Keratin 18 Antibody Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Creative Diagnostics Keratin 18 Antibody Product Portfolio
  36. 6.6.5 Creative Diagnostics Recent Developments
  37. 6.7 CUSABIO
  38. 6.7.1 CUSABIO Company Information
  39. 6.7.2 CUSABIO Business Overview
  40. 6.7.3 CUSABIO Keratin 18 Antibody Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 CUSABIO Keratin 18 Antibody Product Portfolio
  42. 6.7.5 CUSABIO Recent Developments
  43. 6.8 GeneTex
  44. 6.8.1 GeneTex Company Information
  45. 6.8.2 GeneTex Business Overview
  46. 6.8.3 GeneTex Keratin 18 Antibody Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 GeneTex Keratin 18 Antibody Product Portfolio
  48. 6.8.5 GeneTex Recent Developments
  49. 6.9 OriGene Technologies
  50. 6.9.1 OriGene Technologies Company Information
  51. 6.9.2 OriGene Technologies Business Overview
  52. 6.9.3 OriGene Technologies Keratin 18 Antibody Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 OriGene Technologies Keratin 18 Antibody Product Portfolio
  54. 6.9.5 OriGene Technologies Recent Developments
  55. 6.10 ProSci
  56. 6.10.1 ProSci Company Information
  57. 6.10.2 ProSci Business Overview
  58. 6.10.3 ProSci Keratin 18 Antibody Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 ProSci Keratin 18 Antibody Product Portfolio
  60. 6.10.5 ProSci Recent Developments
  61. 6.11 Boster Biological Technology
  62. 6.11.1 Boster Biological Technology Company Information
  63. 6.11.2 Boster Biological Technology Business Overview
  64. 6.11.3 Boster Biological Technology Keratin 18 Antibody Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Boster Biological Technology Keratin 18 Antibody Product Portfolio
  66. 6.11.5 Boster Biological Technology Recent Developments
  67. 6.12 United States Biological
  68. 6.12.1 United States Biological Company Information
  69. 6.12.2 United States Biological Business Overview
  70. 6.12.3 United States Biological Keratin 18 Antibody Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 United States Biological Keratin 18 Antibody Product Portfolio
  72. 6.12.5 United States Biological Recent Developments
7 North America by Country
  1. 7.1 North America Keratin 18 Antibody Sales by Country
  2. 7.1.1 North America Keratin 18 Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Keratin 18 Antibody Sales by Country (2021-2026)
  4. 7.1.3 North America Keratin 18 Antibody Sales Forecast by Country (2027-2032)
  5. 7.2 North America Keratin 18 Antibody Market Size by Country
  6. 7.2.1 North America Keratin 18 Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Keratin 18 Antibody Market Size by Country (2021-2026)
  8. 7.2.3 North America Keratin 18 Antibody Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Keratin 18 Antibody Sales by Country
  2. 8.1.1 Europe Keratin 18 Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Keratin 18 Antibody Sales by Country (2021-2026)
  4. 8.1.3 Europe Keratin 18 Antibody Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Keratin 18 Antibody Market Size by Country
  6. 8.2.1 Europe Keratin 18 Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Keratin 18 Antibody Market Size by Country (2021-2026)
  8. 8.2.3 Europe Keratin 18 Antibody Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Keratin 18 Antibody Sales by Country
  2. 9.1.1 Asia-Pacific Keratin 18 Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Keratin 18 Antibody Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Keratin 18 Antibody Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Keratin 18 Antibody Market Size by Country
  6. 9.2.1 Asia-Pacific Keratin 18 Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Keratin 18 Antibody Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Keratin 18 Antibody Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Keratin 18 Antibody Sales by Country
  2. 10.1.1 South America Keratin 18 Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Keratin 18 Antibody Sales by Country (2021-2026)
  4. 10.1.3 South America Keratin 18 Antibody Sales Forecast by Country (2027-2032)
  5. 10.2 South America Keratin 18 Antibody Market Size by Country
  6. 10.2.1 South America Keratin 18 Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Keratin 18 Antibody Market Size by Country (2021-2026)
  8. 10.2.3 South America Keratin 18 Antibody Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Keratin 18 Antibody Sales by Country
  2. 11.1.1 Middle East and Africa Keratin 18 Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Keratin 18 Antibody Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Keratin 18 Antibody Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Keratin 18 Antibody Market Size by Country
  6. 11.2.1 Middle East and Africa Keratin 18 Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Keratin 18 Antibody Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Keratin 18 Antibody Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Keratin 18 Antibody Value Chain Analysis
  2. 12.1.1 Keratin 18 Antibody Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Keratin 18 Antibody Production Mode & Process
  7. 12.2 Keratin 18 Antibody Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Keratin 18 Antibody Distributors
  10. 12.2.3 Keratin 18 Antibody Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research